D Peter Flynn

Affiliations

  • Evp, Head Of Global Dev at Orexigen Therapeutics Inc. (OREX), 2017-10-17
  • See Remarks at Fate Therapeutics Inc (FATE), 2015-01-07
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
FATE $7.00 5,471 $38,297.00 4,039 2014-06-12 Filing
FATE $7.00 1,017 $7,119.00 4,039 2014-06-11 Filing
FATE $7.00 1,350 $9,450.00 4,039 2014-06-10 Filing
FATE $7.00 1,955 $13,685.00 4,690 2014-06-09 Filing
FATE $7.07 9,793 $69,199.30 5,385 2014-05-01 Filing